EUVIMEDEUVIMED entdecken
Crossref

Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis

Guoyu Wang, Yang Han, Juhua Zhuang, Zhongchao Mai, Wei Xia, Ying Ye

Technology and Health Care · 2025

DOI: 10.3233/thc-241449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology and Health Care, 2025. Verfasst von Guoyu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, Kruppel-Like Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-attributed mortality and the primary liver malignancy in the world. Echinacoside is a phenylethanoid glycoside derived from traditional Chinese medicinal herbs which possessed multiple health benefits on humans, including anti-tumor effects. OBJECTIVE: This study aimed to demonstrate the function of echinacoside in HCC progression and the involvement of miR-30c-5p/FOXD1/KLF12 axis. METHODS: The HepG2 cells were treated by different dose of echinacoside, miR-30c-5p mimic, miR-30c-5p inhibitor, and FOXD1 overexpression lentiviruses or siRNA individually or simultaneously. The cell invasion and migration were measured by transwell assay. RNA and protein levels were tested by RT-PCR and western blot, respectively. The regulatory function of miR-30c-5p on Forkhead box D1 (FOXD1), FOXD1 on Krüppel-like factor 12 (KLF12) was tested by luciferase reporter assay or/and ChIP assay. Meanwhile, a liver cancer lung metastasis mice model was used to examine the functions of echinacoside and miR-30c-5p on HCC metastasis in vivo. Moreover, the correlations among miR-30c-5p, FOXD1, KLF12, and HCC prognosis was analyzed using clinical sample and TCGA database. RESULTS: Based on both in vitro and in vivo investigations, we found that echinacoside could inhibit HCC cell migration, invasiveness, and tumor metastasis, and associated with the enhanced miR-30c-5p/FOXD1/KLF12 axis. Furthermore, through analyzing the interactions among intermediate molecules, we revealed that miR-30c-5p, FOXD1, and KLF12üere clinically relevant with each other in HCC patients, correlated with HCC prognosis, and regulated by echinacoside to contribute in the inhibition of HCC progression. CONCLUSIONS: These findings suggest that echinacoside could inhibit HCC progression, and the mechanism related to the enhanced miR-30c-5p/FOXD1/KLF12 axis. Moreover, the abovementioned intermediate molecules might serve as prospective biomarkers for HCC prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsKruppel-Like Transcription FactorsHumansMiceAnimalsForkhead Transcription FactorsHep G2 CellsDisease ProgressionCell MovementGlycosides

Stichwörter der Autor:innen

EchinacosideFOXD1KLF12hepatocellular carcinomamicroRNA

Substanzen

MicroRNAsechinacosideKruppel-Like Transcription FactorsKLF12 protein, humanForkhead Transcription FactorsMIRN30b microRNA, humanGlycosides

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Nuclear Medicine, Pudong New Area Gongli Hospital, Shanghai, China.
  • Central Laboratory, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Zitieren

APA

Wang, G., Han, Y., Zhuang, J., Mai, Z., Xia, W., & Ye, Y. (2025). Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis. Technology and Health Care. https://doi.org/10.3233/thc-241449

Vancouver

Wang G, Han Y, Zhuang J, Mai Z, Xia W, Ye Y. Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis. Technology and Health Care. 2025. doi:10.3233/thc-241449

BibTeX
@article{Wang2025,
  author = {Wang, Guoyu and Han, Yang and Zhuang, Juhua and Mai, Zhongchao and Xia, Wei and Ye, Ying},
  title = {Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis},
  journal = {Technology and Health Care},
  year = {2025},
  doi = {10.3233/thc-241449}
}
Kostenlos starten →